Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 143,370 | 101,889 | 175,504 | 199,012 | 216,356 |
| Cost of Goods | 12,730 | 14,202 | 15,686 | 13,904 | 12,170 |
| Gross Profit | 130,640 | 87,687 | 159,818 | 185,108 | 204,186 |
| Operating Expenses | 827,447 | 701,901 | 623,212 | 605,804 | 433,394 |
| Operating Income | -696,077 | -614,012 | -462,708 | -419,792 | -229,038 |
| Interest Expense | 19,275 | 13,192 | 13,471 | 2,285 | 7,955 |
| Other Income | -39,274 | -14,974 | 16,328 | 30,798 | 29,056 |
| Pre-tax Income | -754,626 | -642,178 | -459,851 | -391,279 | -207,937 |
| Net Income Continuous | -754,626 | -642,178 | -459,851 | -391,279 | -207,937 |
| Net Income | $-754,626 | $-642,178 | $-459,851 | $-391,279 | $-206,891 |
| EPS Basic Total Ops | -3.77 | -3.71 | -3.27 | -3.03 | -1.83 |
| EPS Basic Continuous Ops | -3.77 | -3.71 | -3.27 | -3.03 | -1.84 |
| EPS Diluted Total Ops | -3.77 | -3.71 | -3.27 | -3.03 | -1.83 |
| EPS Diluted Continuous Ops | -3.77 | -3.71 | -3.27 | -3.03 | -1.84 |
| EBITDA(a) | $-665,618 | $-583,905 | $-430,512 | $-392,333 | $-203,170 |